10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,147 | -26.1% | 149 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,321 | +0.1% | 149 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8,313 | -1.2% | 149 | -35.5% | 0.00% | 0.0% |
| Q4 2022 | $8,418 | +180.6% | 231 | +102.6% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 114 | +137.5% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 48 | -51.5% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -46.7% | 99 | +1.0% | 0.00% | -50.0% |
| Q4 2021 | $15,000 | +66.7% | 98 | +58.1% | 0.00% | +100.0% |
| Q3 2021 | $9,000 | -18.2% | 62 | +6.9% | 0.00% | -50.0% |
| Q2 2021 | $11,000 | -38.9% | 58 | -42.6% | 0.00% | -33.3% |
| Q1 2021 | $18,000 | +157.1% | 101 | +98.0% | 0.00% | +200.0% |
| Q4 2020 | $7,000 | -46.2% | 51 | -66.2% | 0.00% | -66.7% |
| Q2 2020 | $13,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |